FDA Inspection
Mass General Brigham Inc. IRBMass General Brigham Inc. IRB – FDA Inspection, May 23, 2017
Record Details
This FDA Inspection record concerns Mass General Brigham Inc. IRB, with an inspection on May 23, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3bd9b795-4c63-42ff-b6f5-7e260cdd53ce
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1012049
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 56.109(b)Information given to subjects
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mass General Brigham Inc. IRB
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 26, 2022 | NAI | Bioresearch Monitoring | |
| February 14, 2019 | NAI | Bioresearch Monitoring | |
| January 30, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 28, 2009 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Mass General Brigham Inc. IRB
- FDA Inspection 1179420 - 2022-08-26
- FDA Inspection 1083165 - 2019-02-14
- FDA Inspection 770202 - 2012-01-30
- FDA Inspection 608505 - 2009-08-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.